176 related articles for article (PubMed ID: 21659770)
1. Study of diabetic nephropathy in the proteomic era.
Thongboonkerd V
Contrib Nephrol; 2011; 170():172-183. PubMed ID: 21659770
[TBL] [Abstract][Full Text] [Related]
2. Searching for novel biomarkers and new therapeutic targets of diabetic nephropathy using proteomics approaches.
Thongboonkerd V
Contrib Nephrol; 2008; 160():37-52. PubMed ID: 18401160
[TBL] [Abstract][Full Text] [Related]
3. Proteomics and diabetic nephropathy.
Merchant ML; Klein JB
Curr Diab Rep; 2005 Dec; 5(6):464-9. PubMed ID: 16316599
[TBL] [Abstract][Full Text] [Related]
4. Proteomics and diabetic nephropathy.
Merchant ML; Klein JB
Semin Nephrol; 2007 Nov; 27(6):627-36. PubMed ID: 18061845
[TBL] [Abstract][Full Text] [Related]
5. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
6. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
[TBL] [Abstract][Full Text] [Related]
7. Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry.
Smith A; Iablokov V; Mazza M; Guarnerio S; Denti V; Ivanova M; Stella M; Piga I; Chinello C; Heijs B; van Veelen PA; Benediktsson H; Muruve DA; Magni F
Kidney Blood Press Res; 2020; 45(2):233-248. PubMed ID: 32062660
[TBL] [Abstract][Full Text] [Related]
8. Diabetic nephropathy: traditional to proteomic markers.
Moresco RN; Sangoi MB; De Carvalho JA; Tatsch E; Bochi GV
Clin Chim Acta; 2013 Jun; 421():17-30. PubMed ID: 23485645
[TBL] [Abstract][Full Text] [Related]
9. [Novel biomarkers for diabetic nephropathy].
Araki S
Rinsho Byori; 2014 Feb; 62(2):171-9. PubMed ID: 24800493
[TBL] [Abstract][Full Text] [Related]
10. [Early detection by urinary proteome analysis : A new concept in patient management of diabetic nephropathy].
Beige J; Drube J; von der Leyen H; Pape L; Rupprecht H
Internist (Berl); 2020 Oct; 61(10):1094-1105. PubMed ID: 32897404
[TBL] [Abstract][Full Text] [Related]
11. New insights into the use of biomarkers of diabetic nephropathy.
Jha JC; Jandeleit-Dahm KA; Cooper ME
Adv Chronic Kidney Dis; 2014 May; 21(3):318-26. PubMed ID: 24780461
[TBL] [Abstract][Full Text] [Related]
12. Urine proteome analysis by C18 plate-matrix-assisted laser desorption/ionization time-of-flight mass spectrometry allows noninvasive differential diagnosis and prediction of diabetic nephropathy.
Chen CJ; Liao WL; Chang CT; Liao HY; Tsai FJ
PLoS One; 2018; 13(7):e0200945. PubMed ID: 30024955
[TBL] [Abstract][Full Text] [Related]
13. Potential biomarkers associated with diabetic glomerulopathy through proteomics.
Hsu YC; Lei CC; Ho C; Shih YH; Lin CL
Ren Fail; 2015; 37(8):1308-15. PubMed ID: 26364511
[TBL] [Abstract][Full Text] [Related]
14. Insights into predicting diabetic nephropathy using urinary biomarkers.
Khan NU; Lin J; Liu X; Li H; Lu W; Zhong Z; Zhang H; Waqas M; Shen L
Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140475. PubMed ID: 32574766
[TBL] [Abstract][Full Text] [Related]
15. Potential Role of N-Cadherin in Diagnosis and Prognosis of Diabetic Nephropathy.
Ali H; Abu-Farha M; Hammad MM; Devarajan S; Bahbahani Y; Al-Khairi I; Cherian P; Alsairafi Z; Vijayan V; Al-Mulla F; Attar AA; Abubaker J
Front Endocrinol (Lausanne); 2022; 13():882700. PubMed ID: 35712247
[TBL] [Abstract][Full Text] [Related]
16. Early detection and treatment of diabetic nephropathy.
Woredekal Y
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():999-1004. PubMed ID: 18806717
[TBL] [Abstract][Full Text] [Related]
17. Urinary Proteomics for Diagnosis and Monitoring of Diabetic Nephropathy.
Currie G; Delles C
Curr Diab Rep; 2016 Nov; 16(11):104. PubMed ID: 27658932
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of diabetic nephropathy, the present and the future.
Jim B; Santos J; Spath F; Cijiang He J
Curr Diabetes Rev; 2012 Sep; 8(5):317-28. PubMed ID: 22698077
[TBL] [Abstract][Full Text] [Related]
19. Proteomic profile in glomeruli of type-2 diabetic KKAy mice using 2-dimensional differential gel electrophoresis.
Liu X; Yang G; Fan Q; Wang L
Med Sci Monit; 2014 Dec; 20():2705-13. PubMed ID: 25515740
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics in diabetic nephropathy: Unveiling novel biomarkers for diagnosis (Review).
Luo Y; Zhang W; Qin G
Mol Med Rep; 2024 Sep; 30(3):. PubMed ID: 38963028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
